PHAXIAM Therapeutics S.A. Net Foreign Exchange Loss
PHAXIAM Therapeutics S.A. reported Net Foreign Exchange Loss of EUR 3.03 million for the 12-month period ending 2020-12-31, per its 20-F filed 2022-04-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2022-04-27
| Period end | Net Foreign Exchange Loss 12 month |
|---|---|
| 2020-12-31 | 3.03M EUR 20-F · filed 2022-04-27 |